What does MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES do?

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is a wholesaler in Jette. Private Limited, started on 30 July 2021, 1 establishment.

What is the address of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES?

The registered office of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is located at Dieleghemdreef 14, 1090 Jette.

Is MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES still active?

Yes. According to the CBE (30 September 2026) MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is active, legal situation “Normale toestand”, started on 30 July 2021.

Is MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES registered on Peppol?

Yes, MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is registered on the Peppol network with ID 0208:0771869283.

Is MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 July 2021; 4 annual accounts filed, latest fiscal year 2025.

How much profit did MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES make in 2025?

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES recorded a loss after taxes of € 12,515 in financial year 2025.

What is the revenue of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES?

As a small company, MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 20,502.

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES - Jette

Q: What is the enterprise number of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES?

The enterprise number of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES is BE0771869283.

Q: When was MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES founded?

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES was founded on 30 July 2021.

Dossier MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES, printed on 30 September 2026 from databakkes.be/en/0771869283/medical-and-pharmaceutical-services-and-supplies. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES from Jette, company number BE0771869283, closed financial year 2025 with a result of € -12,515 after tax. For that financial year MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES recorded a gross margin of € 20,502 and equity of € 58,434. Compared with financial year 2023, the result moved from € 30,802 to € -12,515. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 2, 2026.

What it is worth Healthy

€ 58,434

▼ 3% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -12,515

▼ still € 30,802 profit in 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 19,098

▼ 24% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 13,434.

People and assets in 2025

Wage cost

€ 15,735

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 650

▼ 97% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,193

▲ 109% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,682

▼ 65% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2025	Change 2023 → 2025
Revenue	-	€ 90,000 Revenue 2022: € 90,000 First fiscal year in the series	-	-
Gross margin	€ 0 Gross margin 2021: € 0 First fiscal year in the series	€ -9,840 Gross margin 2022: € -9,840 Unchanged (€ 0) Unfavourable step	€ 57,108 Gross margin 2023: € 57,108 ▲ € 66,947 vs 2022 (€ -9,840) Favourable step	€ 20,502 Gross margin 2025: € 20,502 ▼ 64% vs 2023 (€ 57,108) Unfavourable step	▼ 64%
Profit after taxes	€ 0 Profit after taxes 2021: € 0 First fiscal year in the series	€ -15,798 Profit after taxes 2022: € -15,798 Unchanged (€ 0) Unfavourable step	€ 30,802 Profit after taxes 2023: € 30,802 ▲ € 46,600 vs 2022 (€ -15,798) Favourable step	€ -12,515 Profit after taxes 2025: € -12,515 ▼ € 43,316 vs 2023 (€ 30,802) Unfavourable step	▼ € 43,316
Equity	€ 45,000 Equity 2021: € 45,000 First fiscal year in the series	€ 29,202 Equity 2022: € 29,202 ▼ 35% vs 2021 (€ 45,000) Unfavourable step	€ 60,003 Equity 2023: € 60,003 ▲ 105% vs 2022 (€ 29,202) Favourable step	€ 58,434 Equity 2025: € 58,434 ▼ 3% vs 2023 (€ 60,003) Unfavourable step	▼ 3%
Total debts	€ 0 Total debts 2021: € 0 First fiscal year in the series	€ 36,590 Total debts 2022: € 36,590 Unchanged (€ 0) Unfavourable step	€ 20,451 Total debts 2023: € 20,451 ▼ 44% vs 2022 (€ 36,590) Favourable step	€ 9,875 Total debts 2025: € 9,875 ▼ 52% vs 2023 (€ 20,451) Favourable step	▼ 52%
Cash	€ 45,000 Cash 2021: € 45,000 First fiscal year in the series	€ 4,511 Cash 2022: € 4,511 ▼ 90% vs 2021 (€ 45,000) Unfavourable step	€ 25,265 Cash 2023: € 25,265 ▲ € 20,754 vs 2022 (€ 4,511) Favourable step	€ 19,098 Cash 2025: € 19,098 ▼ 24% vs 2023 (€ 25,265) Unfavourable step	▼ 24%
Retained profit	€ 0 Retained profit 2021: € 0 First fiscal year in the series	€ -15,798 Retained profit 2022: € -15,798 Unchanged (€ 0) Unfavourable step	€ 15,003 Retained profit 2023: € 15,003 ▲ € 30,802 vs 2022 (€ -15,798) Favourable step	€ 13,434 Retained profit 2025: € 13,434 ▼ 10% vs 2023 (€ 15,003) Unfavourable step	▼ 10%
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 25,000 Bank debt 2022: € 25,000 Unchanged (€ 0) Unfavourable step	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 25,000) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 45,000 Balance sheet total 2021: € 45,000 First fiscal year in the series	€ 65,791 Balance sheet total 2022: € 65,791 ▲ 46% vs 2021 (€ 45,000) Unchanged	€ 80,454 Balance sheet total 2023: € 80,454 ▲ 22% vs 2022 (€ 65,791) Unchanged	€ 68,309 Balance sheet total 2025: € 68,309 ▼ 15% vs 2023 (€ 80,454) Unchanged	▼ 15%

Key figures of MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES?

What happened at MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 2, 2026 New annual accounts for financial year 2025: loss of € 12,515 (▼ € 43,316 vs 2023). Source: NBB ↗
Jul 30, 2021 New establishment in Jette. KBO
Jul 30, 2021 Start of the company according to the CBE. KBO

In short

From € 0 profit in 2021 to € 12,515 loss in 2025.

Paid € 5,573 in corporate taxes since 2021.

Best year ever: 2023, with € 30,802 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES? We notify you, reason included.

Follow MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Dieleghemdreef 14

1090 Jette

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0771.869.283

VAT number

BE 0771.869.283

Registered office

Dieleghemdreef 14, 1090 Jette

Names & denominations

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES · MEDPHAS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

30 July 2021

Peppol

Active · Active since 20 Oct 2025

Activities · NACE

Groothandel in farmaceutische en medische artikelen

Handelsbemiddeling in de groothandel in andere specifieke goederen

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES